1. 1046OPreliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations. (23rd October 2018) Authors: Ho, A L; Chau, N; Bauman, J; Bible, K; Chintakuntlawar, A; Cabanillas, M E; Wong, D J; Braña Garcia, I; Brose, M S; Boni, V; Even, C; Razaq, M; Mishra, V; Bracken, K; Wages, D; Scholz, C; Gualberto, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗